Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-06

Clinical Trial Update: Post Market Non-Inferiority Study Comparing Triojection® to Discectomy for Lumbar Disc Herniation [Phase 4]

View source ↗

Summary

Post-market Phase 4 study update evaluating non-inferiority of Triojection compared with discectomy for lumbar disc herniation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triojection

Snippet

Sponsor: Minimus Spine, Inc | Conditions: Lumbar Disc Herniation | Phase 4 | Status: UNKNOWN